Rectroclavicular Block in Orthopedic Surgey

NCT06406647 | Recruiting DMC

• 1 other identifier: Newvalley anesthesia
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

The ultrasound-guided retroclavicular approach to the infraclavicular region (RAPTIR) brachial plexus block has gained popularity as a relatively easy-to-perform nerve block that provides reliable and dense anesthesia to the upper extremity with a single injection. The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig first described the block's use in the ED setting for a variety of indications . This nerve block has classically been described to provide extensive anesthesia for procedures distal to the shoulder, such as elbow dislocations, distal radius fractures, and surgical procedures.

Conditions

Pain Management

Outcome Measures

Primary Outcomes (1)

• numerical rating pain scale .

  0= no pain , 10 = sever pain

  24 hours

Study Arms (2)

ketamine with bupicavaine

ACTIVE COMPARATOR

(bupivacaine+ ketamine): 40patients received 40 ml of bupivacaine 0.25%(in total 100mg)+1mg per Kg of ketamine)

Other: retrocalvicular block

bupicavacine (control group)

ACTIVE COMPARATOR

(Bupivacaine): 40patients received40 ml of bupivacaine 0.25%(in total 100 mg)+2 ml saline.

Other: retrocalvicular block

Interventions

retrocalvicular block OTHER

retrocalvicular block in upper limb orthopedic Surgey

bupicavacine (control group); ketamine with bupicavaine

Eligibility Criteria

• Age: 20 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients undergoing upper limb orthopedic surgery,

You may not qualify if:

• \- Contraindications to regional block (coagulopathy, infection at the needle insertion site, or diaphragmatic paralysis).
• Altered conscious level.
• Pregnancy.
• Body mass index (BMI \> 35).
• Patients who have difficulty understanding the study protocol.
• Patients who have any known contraindication to study medications.
• Patient refusal.

Sponsors & Collaborators

• New Valley University: lead

Study Sites (1)

Faculty of Medicine

Asyut, Egypt

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• ahmed ismail, lecture

  New Valley University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

ahmed ismail, lecture

CONTACT

01097845491; ahmed_ismail87@med.nvu.edu.eg

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: lecture of anesthesia and ICU

Study Record Dates

• First Submitted: May 6, 2024
• First Posted: May 9, 2024
• Study Start: June 1, 2024
• Primary Completion: January 1, 2025
• Study Completion: February 1, 2025
• Last Updated: June 5, 2024

Record last verified: 2024-06

Locations

EG (1)